Chloroquine*
- BP-S-6-Medicinal Chemistry III
- Mar 28
- 1 min read
Chemical Structure / Formula of Chloroquine*
Formula: C18H26ClN3
Structure: 4-Aminoquinoline with an ethyl-diethylamine side chain.

Mechanism of Action
Inhibits heme polymerase, preventing detoxification of toxic free heme, leading to Plasmodium death.
Accumulates in the food vacuole of Plasmodium spp.
Uses
First-line for non-resistant Plasmodium spp. (P. vivax, P. ovale, P. malariae).
Autoimmune diseases (RA, lupus: due to immunomodulatory effects).
Side Effects
Retinopathy (bull’s eye maculopathy): irreversible.
Pruritus (especially in dark-skinned individuals).
GI disturbances, QT prolongation, hemolysis in G6PD deficiency.
Structure-Activity Relationship (SAR) of Chloroquine
Structural Feature | Role in Activity |
4-Aminoquinoline ring | Essential pharmacophore for antimalarial activity. |
Basic side chain (diethylaminoalkyl) | Crucial for accumulation in acidic food vacuole of the parasite. Chain length affects potency (typically 3 carbon atoms in linker is optimal). |
Electron-donating groups on aromatic ring | Can improve potency and reduce toxicity. |
Halogen substitution (e.g., Cl at position 7) | Enhances lipophilicity and improves penetration into parasitic vacuole. |
N-alkylation of side chain | Small alkyl groups tolerated; bulky substituents reduce activity. |
Synthesis of Chloroquine
